News & Blog

Tag Archives: FDA

Congress Delivers Brain Tumor Community Holiday Gift

More funding for NIH to raise all ships, and specific funding for pediatric brain tumors, is welcome! More money will be available for brain tumor research in 2016, thanks to a year-end budget deal in the United States Congress that was reached today. The “omnibus” spending bill that sets government spending levels and priorities for […]

Survey Results: Clinical Trial Participation

  National Brain Tumor Society, in conjunction with neuro-oncologists, scientific researchers, and the biopharmaceutical industry, is constantly looking for new and better treatments for patients. However, scientific progress in a laboratory does not necessarily always lead to new treatments for patients. First, those laboratory results need to be evaluated and confirmed in high quality clinical trials to ensure […]

GBM AGILE: A Community Galvanized

“GBM is just unacceptable…we no longer accept the status quo.” – Dr. Anna Barker Last week, you likely took notice of the press release, guest blog from Dr. Anna Barker, and a flurry of social media activity related to the announcement of the GBM AGILE coalition and clinical trial. As NBTS is co-chairing the GBM […]

Share